Faculty Translational Science Pilot Award
These awards support projects that address a translational challenge or barrier with a primary goal to provide the groundwork for faculty to obtain subsequent funding. The UR CTSI requires that faculty awardees demonstrate academic productivity through publication of the research.
This funding opportunity is not currently open.
Notify When Available
Return to: Funding Directory
Eligibility
Funding Amount
This TS01 award provides up to $50,000 for up to one year.
Important Dates
Apply
Application Selection
Projects supported by this program must address a translational challenge or barrier and meet the definition of translational science research. Translational science is the field of investigation focused on understanding the scientific and operational principles underlying each step of the translational research process.
Highly competitive applications will address a specific translational barrier using a disease or use case in a way that could convincingly be applied across multiple diseases, conditions or scientific fields.
Contact
If you have questions regarding this RFA, please contact one of the following:
General inquiries
Karen Grabowski – ctsi@urmc.rochester.edu
Scientific and Peer Review contacts
OJ Sahler, MD - oj_sahler@urmc.rochester.edu
Edward Schwarz, PhD - edward_schwarz@urmc.rochester.edu
Financial contact
Mary Lyons - mary_lyons@urmc.rochester.edu
Awardees and Projects
Use of implementation science to adapt a community health worker model to improve outcomes among historically marginalized children with asthma.
Jessica Stern, MD, MS
Assistant Professor, Medicine M&D-Immunology/Rheumatology Division
A novel, smart "Rapid Decision" AI to bridge the major gap in adaptive radiotherapy
Dandan Zheng, PHD, MS
Professor of Radiation Oncology, and Director of Medical Physics
Understanding the kidney replacement therapy decision-making process
Suma Prakash, M.D.
Associate Professor of Clinical Medicine in the Department of Medicine, Nephrology
Significance of symptom onset-To-angiography time in non-ST-segment elevation myocardial infarction
Sukardi Suba, Ph.D., R.N.
Postdoctoral Research Associate at the University of Rochester School of Nursing
Desmosome-nuclear lamina coupling: Implications for arrhythmogenic cardiomyopathy
Eric M. Small, Ph.D.
Associate Professor of Medicine in the Aab Cardiovascular Research Institute, Pharmacology and Physiology, and Biomedical Engineering
Dissecting cellular heterogeneity and cross-talk in Cam FAI and hip osteoarthritis joint synovial tissue by spatial transcriptomics sequencing
Chia-Lung Wu, Ph.D.
Assistant Professor of Orthopaedics and Biomedical Engineering
Is Concentrated Insulin in Human Milk-Derived Fortifiers Linked with Increased Hypoglycemia in the Neonatal Intensive Care Unit?
Bridget Young, Ph.D.
Assistant Professor of Pediatric Allergy/Immunology and Public Health Sciences
Using neural correlates of story comprehension to reveal mild cognitive impairment in early Alzheimer's
Andrew J. Anderson, Ph.D.
Research Assistant Professor in the Department of Neuroscience
Mitochondrial genetics and oxidative function as determinants of bone health
Roman Eliseev, M.D., Ph.D.
Associate Professor of Orthopaedics and Pharmacology and Physiology
Role of the Alternative Complement Pathway in Systemic Sclerosis Associated Pulmonary Hypertension (SSc-PAH)
Benjamin Korman, M.D.
Assistant Professor of Allergy/Immunology and Rheumatology
Preventing Premature Death among Patients with Serious Opioid Related Infection
Marc Swogger, Ph.D.
Associate Professor of Psychiatry
Kenneth Conner, PsyD, MPH
Professor of Emergency Medicine
Predictors of Functional Impairment in Older Adults with Head & Neck Cancer
Ronald Maggiore, M.D.
Assistant Professor of Hematology/Oncology
Targeting Vitamin D Receptor for Treatment of Pancreatic Cancer
Rakesh Singh, M.D., MPhil
Research Associate Professor of Obstetrics and Gynecology
Piloting Interventions to Improve Adherence to Cervical Cancer Screening in ED
David Adler, M.D., MPH
Professor of Emergency Medicine, Pediatrics and Public Health Sciences
Cardiac Biomarkers for Sudden Unexpected Death in Epilepsy
David Auerbach, Ph.D.
Assistant Professor of Medicine in the Aab Cardiovascular Research Institute
Patient-specific simulated procedure rehearsal for minimally invasive surgery
Ahmed Ghazi, M.D., MSc
Assistant Professor of Urology
Developing Social-Network Measures of Medical Staff Interactions in Nursing Homes
Orna Intrator, Ph.D.
Professor of Public Health Sciences
Sensitivity to Envelope Structure in Children with Otitis Media and Hearing Loss
Margo McKenna Benoit, M.D.
Associate Professor of Pediatrics and Otolaryngology
Targeting of small molecule inhibitors for the treatment of myelogenous leukemia
Benjamin Frisch, Ph.D.
Research Assistant Professor of Hematology/Oncology
Effect of Statin therapy in combination with QT prolonging drugs
Coeli Lopes, Ph.D.
Research Assistant Professor of Medicine in the Aab Cardiovascular Research Institute
MeTC7 a novel Vitamin-D receptor antagonist for immunotherapy of ovarian cancer
Rakesh Singh, Ph.D., MPhil
Research Assistant Professor of Obstetrics and Gynecology
Assessment of Forteo as a Therapeutic to Treat Knee Osteoarthritis
Emily Carmody, M.D.
Assistant Professor of Orthopaedic
A Pilot Study of Mexiletine for Muscle Cramps in Charcot Marie tooth Disease
David Herrmann, M.D.
Professor of Neurology
Vitamin D Kinetics During Pregnancy
Eva Pressman, M.D.
Chair and Professor of Obstetrics and Gynecology
Identification of the Effective Vascular Progenitors for Bone Repair and Regeneration
Xingping Zhang, M.D., Ph.D.
Associate Professor of Orthopaedics
Improving Mitochondrial Function in Mesenchymal Stem Cells to Accelerate Fracture Repair in Aging
Roman Eliseev, M.D.
Assistant Professor, Center for Musculoskeletal Research
Chemoprevention of bladder cancer through estrogen receptor modulation
Elizabaeth Guancial, M.D.
Assistant Professor of Medicine (Hematology and Oncology)
Role of the Gut Microbiome in Preventing Allergic Disease
R. John Looney, M.D.
Professor of Medicine (Allergy, Immunology and Rheumatology)
Exosomes from bladder cancer patients can serve as biomarkers of disease progression
Edward Messing, M.D.
Professor of Urology
Novel microRNA Based Therapy to Improve CD4+ T-cell Responses to Vaccination
Craig Morrell, DVM, Ph.D.
Associate Professor of Medicine
The Role of Microparticle-Derived Thy-1 (CD90) in Type 2 Diabetes Mellitus
Sherry Spinelli, Ph.D.
Research Associate Professor of Pathology and Laboratory Medicine
Quantifying Tumor Diversity to predict and target Cancer progression
W. Richard Burack, M.D., Ph.D.
Associate Professor, Pathology and Laboratory Medicine
Osteoblastic Function in Human Leukemia
Laura Calvi, M.D.
Associate Professor, Medicine (Endocrinology)
Inhibition of G protein beta/gamma signaling as a therapeutic approach to treatment of lupus
Alan Smrcka, Ph.D.
Professor, Pharmacology and Physiology
Improving Platelet Storage and Transfusion Outcomes with PPARγ Ligands
Neil Blumberg, M.D.
Professor, Pathology and Laboratory Medicine
High throughput sorting of rare cells from blood using Microbubble Arrays
Lisa DeLouise, Ph.D., M.P.D.
Associate Professor, Dermatology
Characterization of antifibrotic effects of CDDO, a small electrophilic compound
Ajit Kulkarni, Ph.D.
Research Assistant Professor, Medicine (Pulmonary/Critical Care Division)
Therapeutic targeting of CXCR7 in malignant glioma by small molecule antagonist
Yang Liu, BM, Ph.D.
Research Assistant Professor, Neurosurgery
Comparative Effectiveness of practice-based diabetes prevention programs
Nancy Bennett, M.D., M.S.
Director of the Center for Community Health
Protease activated cytokines: a novel methodology for the delivery and activation of cytokines
John Frelinger, Ph.D.
Professor of Microbiology and Immunology
Microparticle miRNAs as transcellular messengers in diabetes and vascular disease
Sherry Spinelli, Ph.D.
Research Associate Professor of Pathology and Laboratory Medicine
Notify When Available
This funding opportunity is not currently open. Complete the form below to be notified when it is available again.
The principal investigator (PI) on all proposals must be faculty members with a primary appointment at the University of Rochester. If there are MPIs, one of the members of the applying team must have a primary faculty appointment at the University of Rochester. This team member will be the contact PI for the project.
Faculty may participate as PI, MPI, Faculty Sponsor/Primary Mentor on only one submission per award category. Faculty may participate in multiple submissions per category as co-investigator or co-mentor. Any faculty member who has a current grant with overlapping aims is not eligible to apply.
The following dates apply to the current solicitation:
- Initial Letter of Intent (LOI) and Specific Aims due - October 21, 2024 at 5:00 PM
- Notification of full proposal solicitation - December 9, 2024
- Full proposals due - January 27, 2025 at 5:00 PM
- Notifications of Award - March 24, 2025
- Anticipated start date - July 1, 2025
- Award period ends - June 30, 2026
Solicitation and Review Process
Phase 1: Applicants submit a two-page Letter of Intent (LOI) stating their specific aims and summarizing their proposals. The UR CTSI review committee specific to each submission category will evaluate, score, and discuss the LOIs.
Phase 2: A subset of applicants will be invited to submit full proposals. The UR CTSI Review Committee specific to each submission category will engage in a formal study section-style discussion and scoring meeting for proposals. Funding recommendations go to the UR CTSI Executive Team for a final review and decision on funding.
The Pilot Studies Funding Attestation must be submitted with the initial Letter of Intent and full proposal.
Note: All animal and human subject protocols must be approved by NCATS, the NIH institute funding the UR CTSI, prior to the start date. No funds for research project costs may be released until all required human subjects and animal welfare approvals have been received.
Please note that UR CTSI awards and funding are dependent upon the renewal of grants from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH).